Michael Benkowitz sold $10.7M of United Therapeutics (UTHR)

Executed Feb 9, disclosed Feb 10, 1 day later.

Value, as filed

$10.7M

22,500 sh across 2 lots

Executed

Feb 9

the trade date, as filed

Disclosed

Feb 10

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael Benkowitz PRESIDENT AND COO profile →

Michael Benkowitz (PRESIDENT AND COO) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales, 3 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $14.2M of UTHR (30,214 sh across 13 lots, as filed), executed Jan 20.

The name

UTHR

United Therapeutics Corporation UTHR · Healthcare · 343 filings in 24 months ticker →

Healthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Benkowitz in UTHR

UTHRSALE United Therapeutics Corporation $6.8M
14,440 sh across 2 lots
Exec Feb 23
Filed Feb 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $10.8M
22,500 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $10.6M
22,500 sh across 2 lots
Exec Feb 2
Filed Feb 3 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $14.2M
30,214 sh across 13 lots
Exec Jan 20
Filed Jan 28 · 5:30 PM ET † UTHRSALE United Therapeutics Corporation $6.7M
14,327 sh across 11 lots
Exec Jan 20
Filed Jan 28 · 5:30 PM ET † UTHRSALE United Therapeutics Corporation $10.8M
22,500 sh across 2 lots
Exec Jan 12
Filed Jan 13 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $3.7M
7,674 sh across 13 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $7.1M
14,625 sh across 14 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET